Amid pollution woes, Asthma drug demand drives pharma retail market growth in November
Heavy pollution across several parts of the country also contributed to increased sales of respiratory medications, particularly Foracort, used for asthma and related conditions.
Foracort emerged as the top-selling drug for the month, recording sales of Rs 82 crore with a 2% growth. Antibiotic Augmentin secured the second spot with Rs 76 crore in sales and a 9% growth, while antidiabetic drug Glycomet GP ranked third with flat sales of Rs 69 crore.
Among therapeutic categories, urology led the growth at 18%, followed by derma (16%), cardiac (13%), and pain-relief (13%) segments. Pain-relief medication Zerodol SP saw a remarkable 22% growth, while other high-performing drugs like Ryzodeg, Rosuvas, Cilacar, Rybelsus, and Duphalac posted over 20% month-on-month growth, as per the TOI report.
Sun Pharma maintained its leadership in the market with an 8% share of the Rs 2.28 lakh crore retail pharma sector. Cipla and Dr. Reddy's also saw their market shares rise in November.
Design
Canva Magic Write: Ideas to Stunning Slides in No Time
By — Prince Patni, Software Developer (BI, Data Science)
Web Development
C++ Fundamentals for Absolute Beginners
By — Metla Sudha Sekhar, IT Specialist and Developer
Web Development
Mastering Full Stack Development: From Frontend to Backend Excellence
By — Metla Sudha Sekhar, IT Specialist and Developer
Finance
A2Z Of Money
By — elearnmarkets, Financial Education by StockEdge
Artificial Intelligence(AI)
Master in Python Language Quickly Using the ChatGPT Open AI
By — Metla Sudha Sekhar, IT
